Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CANNAPHARMARX, INC.CPMD · Entity 8539 | Director · Chief Executive Officer | February 26, 2019 | April 30, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CANNAPHARMARX, INC.
Report date February 26, 2019 · Filed April 30, 2020 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | IndirectSee Footnote | 7,988,963 |
Reported balance
Holding disclosure · report date 2019-02-26 · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · Balance 7,988,963 F1: Shares are held in the name of PLC International Investments, Inc. of which Reporting Person is the 100% owner and thus the control person having dispositive powers over the shares. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares are held in the name of PLC International Investments, Inc. of which Reporting Person is the 100% owner and thus the control person having dispositive powers over the shares.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 08, 2019 Filed Apr 29, 2020 23:40 UTC | CANNAPHARMARX, INC. CPMD · Entity 8539 | SaleCommon Stock | 1,000,000 | $0.25 | $250,000.00 |
DisclosureSEC source: 0001683168-20-001345 · ownership.xml · nonDerivative · entry 1 Colvin Dominic · CIK 0001493405 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 6,988,963 F1 · ownership.nature: Shares are held in the name of PLC International Investments, Inc. of which Reporting Person is the 100% owner and thus the control person having dispositive powers over the shares. On October 2, 2019, Reporting Person personally loaned the Issuer $250,000 evidenced by Promissory Note utilizing funds from this sale. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.